Yike Tang, Feng Tian, Xiaochen Zhu, Guotao Chu, Liangang Liu, Hsin‐Ju Hsieh et al. BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints. // Pharmaceutical Statistics. – 2026. – DOI: 10.1002/pst.70127. – URL: https://onlinelibrary.wiley.com/doi/10.1002/pst.70127?af=R
Yike Tang, Feng Tian, Xiaochen Zhu, Guotao Chu, Liangang Liu, Hsin‐Ju Hsieh, & Shu‐Pang Huang (2026). BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints. Pharmaceutical Statistics. https://doi.org/10.1002/pst.70127
Yike Tang, et al. “BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints.” Pharmaceutical Statistics, 2026. doi:10.1002/pst.70127.
@article{Tang2026,
title = {BEACON: An Adaptive Bayesian Early‐Phase Oncology Trial Design Integrating Dose Optimization and Proof‐of‐Concept Across Survival and Binary Endpoints},
author = {Tang, Yike and Tian, Feng and Zhu, Xiaochen and Chu, Guotao and Liu, Liangang and Hsieh, Hsin‐Ju and Huang, Shu‐Pang},
journal = {Pharmaceutical Statistics},
year = {2026},
doi = {10.1002/pst.70127},
url = {https://onlinelibrary.wiley.com/doi/10.1002/pst.70127?af=R}
}